SNSE- Sensei Biotherapeutics, Inc.

Insider activity in SNSE over the last quarter tilts toward selling: insiders offloaded a net 34,359 shares worth roughly $600K.

Classified under Biotechnology (Health Care sector), SNSE's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Parikh Anand Kiran	1.24M	-	-
Pres	Gerry Christopher	220.0K	-	-
10%	Peyer James	130.6K	$2.61M	-
10%	Cambrian Biopharma Inc	130.6K	$2.61M	-
Other	Craver Josiah	80.0K	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 26, 2026	Stephenson Brian C	Chief Financial Officer	Buy	15,641	$25.65	$401,268.52	+7.6%	-	-
Jun 1, 2026	Peyer James	10% Owner, See Remarks Below	Sell	25,000	$20.02	$500,542.64	-8.7%	-	-
Jun 1, 2026	Cambrian Biopharma Inc	10% Owner	Sell	25,000	$20.02	$500,542.64	-8.7%	-	-
Dec 9, 2025	Peyer James	-	Sale+OE	6,612	$8.25	$54,574.77	-1.0%	+270.1%	-
Dec 9, 2025	Cambrian Biopharma Inc	-	Sale+OE	6,612	$8.25	$54,574.77	-1.0%	+270.1%	-
Dec 5, 2025	Cambrian Biopharma Inc	-	Sell	21,295	$10.93	$232,689.97	-3.1%	+213.8%	-
Dec 5, 2025	Peyer James	-	Sell	21,295	$10.93	$232,689.97	-3.1%	+213.8%	-
Sep 11, 2023	Celebi John	President And CEO	Buy	500	$0.85	$425.00	+0.5%	-17.8%	-31.2%
Jun 1, 2023	Apeiron Investment Group Ltd.48	10% Owner	Sell	3,441,661	$1.58	$5,437,824.38	-100%	-29.5%	-49.3%
Feb 23, 2023	Apeiron Investment Group Ltd.48	10% Owner	Buy	2,200	$1.61	$3,539.03	-	-0.6%	-53.4%